Challenges in Treatment of Primary Sjogren’s Syndrome and Opportunities for Chinese Medicine

作     者：HOU Jia-qi XUE Luan HOU Jia-qi;XUE Luan

作者机构：Department of Rheumatology and ImmunologyYueyang Hospital of Integrated Traditional Chinese and Western MedicineShanghai University of Traditional Chinese MedicineShanghai(200437)China 

出 版 物：《Chinese Journal of Integrative Medicine》 (中国结合医学杂志（英文版）)

年 卷 期：2020年第26卷第7期

页      面：483-485页

核心收录：

学科分类：100506[医学-中医内科学] 1006[医学-中西医结合] 1005[医学-中医学] 100602[医学-中西医结合临床] 10[医学] 

基　　金：Supported by National Natural Science Foundation of China(No.81573925) Scientific Research Program of Shanghai Science and Technology Commission(No.17401935500) Accurate Diagnosis and Treatment of Difficult Diseases from Shanghai Hospital Development Center(No.16CR2047B) 

主　　题：primary Sjogren's syndrome immunomodulatory agents Chinese medicine 

摘      要：Primary Sjogren’s syndrome is a chronic autoimmune disease that can lead to systemic *** present,immunomodulatory agents have not shown good efocacy,many patients in China seek Chinese medicine *** medicine can comprehensively improve the symptoms of patients through Chinese pattern diagnosis and individualized *** researches are providing scientioc bases for the therapeutic effect of Chinese *** Chinese medicine treatment can be integrated into the conventional management of primary Sjogren’s syndrome.